Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.
Soley Therapeutics has raised $200.0M in total funding. The most recent round was Series C. The last funding was announced in January 2026.
Soley Therapeutics's investors include Doug Leone Family Fund, HRTG Partners, Breyer Capital, Surveyor Capital, GordonMD Global Investments.
Soley Therapeutics is headquartered in San Francisco, United States.
Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.
Soley Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Soley Therapeutics — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/soley-therapeutics. Accessed September 13, 2026.
VCBacked. (2026). Soley Therapeutics — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/soley-therapeutics
{{cite web |title=Soley Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/soley-therapeutics |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated